本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ADC Therapeutics SA

1.07
-0.0400-3.60%
盤後1.070.00000.00%19:30 EDT
成交量:98.91萬
成交額:105.45萬
市值:1.36億
市盈率:-1.47
高:1.16
開:1.13
低:1.04
收:1.11
52周最高:4.98
52周最低:0.7796
股本:1.27億
流通股本:8,856.21萬
量比:0.63
換手率:1.12%
股息:- -
股息率:- -
每股收益(TTM):-0.7271
每股收益(LYR):-1.1224
淨資產收益率:-705.53%
總資產收益率:-19.57%
市淨率:-0.60
市盈率(LYR):-0.95

資料載入中...

2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/04/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/21

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/16

SEC問詢函

Form CORRESP - Correspondence
2023/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership